| Parameter . | Result . | Reference rangea . |
|---|---|---|
| ANC | 1,140 (↓) | 1,500–7,700/ml |
| CD14+ monocytes | 330 | 165–780/ml |
| ALC | 670 | 1,000–4,800/µl |
| CD3+ T cells | 387 (↓); 62% | 661–2,224/ml |
| CD4+ T cells | 281 (↓); 45% | 356–1,573/ml |
| CD8+ T cells | 92 (↓); 15% | 113–804/ml |
| Circulating Tfh cellsb | 12% | 13.4–24.9% |
| Partial effector Tfh cellsc | 22.9% (↑) | 9.26–11.1% |
| Resting memory Tfh cellsd | 30.6% (↓) | 60.5–69% |
| T reg cellse | 7.74% | 6.85–8.65% |
| CD19+ B cells | 159; 26% | 143–396/ml |
| Naive Bf | 97.8% (↑) | 14–58% |
| Switched memory Bg | 0.16% (↓) | 23–60% |
| CD3−/16+ or 56+ | 67 (↓); 11% | 82–594/ml |
| CD11c+ conventional DCh | 3.29% | 1.75–4.59% |
| CD1c+i | 3.38% | 0.95–3.18% |
| CD141+j | 3.01% | 1.33–3.09% |
| Parameter . | Result . | Reference rangea . |
|---|---|---|
| ANC | 1,140 (↓) | 1,500–7,700/ml |
| CD14+ monocytes | 330 | 165–780/ml |
| ALC | 670 | 1,000–4,800/µl |
| CD3+ T cells | 387 (↓); 62% | 661–2,224/ml |
| CD4+ T cells | 281 (↓); 45% | 356–1,573/ml |
| CD8+ T cells | 92 (↓); 15% | 113–804/ml |
| Circulating Tfh cellsb | 12% | 13.4–24.9% |
| Partial effector Tfh cellsc | 22.9% (↑) | 9.26–11.1% |
| Resting memory Tfh cellsd | 30.6% (↓) | 60.5–69% |
| T reg cellse | 7.74% | 6.85–8.65% |
| CD19+ B cells | 159; 26% | 143–396/ml |
| Naive Bf | 97.8% (↑) | 14–58% |
| Switched memory Bg | 0.16% (↓) | 23–60% |
| CD3−/16+ or 56+ | 67 (↓); 11% | 82–594/ml |
| CD11c+ conventional DCh | 3.29% | 1.75–4.59% |
| CD1c+i | 3.38% | 0.95–3.18% |
| CD141+j | 3.01% | 1.33–3.09% |
Because the measurements were performed in various clinical laboratories, ↓ indicates that at least one of the measurements during this time was lower than the reference range of the corresponding laboratory. ↑ indicates that at least one measurement was higher than the controls. ANC, absolute neutrophil count; ALC, absolute lymphocyte count.
Reference ranges from HCs.
CD45RA− CD4+ CXCR5+.
CD45RA− CD4+ CXCR5+ PD-1hi CCR7lo.
CD45RA− CD4+ CXCR5+ PD-1lo CCR7hi.
CD4+ Foxp3+.
CD45+ CD19+ CD27− IgD+.
CD45+ CD19+ CD27+ IgD−.
Lin1− HLA-DR+ CD11c+.
Lin1− HLA-DR+ CD11c+ CD1c+.
Lin1− HLA-DR+ CD11c+ CD141+.